Search research articles
Contact Us
Filters
Showing results (51-60 of 144) with videos related to
Page
of 15
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2009
Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain
Jürgen E Andrich, Michael Wobben, Peter Klotz, et al.
BMC Neurology
|
October 22, 2013
Oral and dental health in Huntington's disease - an observational study
Carsten Saft, Jürgen E Andrich, Thomas Müller, et al.
Brain and Behavior
|
October 18, 2020
Altered third-party punishment in Huntington's disease: A study using neuroeconomic games
Martin Brüne, Sarah Maria von Hein, Christian Claassen, et al.
BMC Medical Genetics
|
October 6, 2005
Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)
Larissa Arning, Peter H Kraus, Carsten Saft, et al.
Neuropsychologia
|
January 29, 2008
fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease
Carsten Saft, Anne Schüttke, Christian Beste, et al.
Neurology
|
May 27, 2021
Teaching Video NeuroImage: New <i>STUB1</i> Variant Causes Chorea, Tremor, Dystonia, Myoclonus, Ataxia, Depression, Cognitive Impairment, Epilepsy, and Superficial Siderosis
Carsten Saft, Sabine Skodda, Huu Phuc Nguyen, et al.
Plos One
|
December 7, 2007
Time processing in Huntington's disease: a group-control study
Christian Beste, Carsten Saft, Jürgen Andrich, et al.
Neurogenetics
|
June 1, 2010
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1
Elahe Taherzadeh-Fard, Carsten Saft, Stefan Wieczorek, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 15, 2013
Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R
Eugen Kloster, Carsten Saft, Denis A Akkad, et al.
BMC Neurology
|
March 2, 2006
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
Carsten Saft, Thorsten Lauter, Peter H Kraus, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 144) with videos related to
Sort By:
Page
of 15
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2009
Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain
Jürgen E Andrich, Michael Wobben, Peter Klotz, et al.
BMC Neurology
|
October 22, 2013
Oral and dental health in Huntington's disease - an observational study
Carsten Saft, Jürgen E Andrich, Thomas Müller, et al.
Brain and Behavior
|
October 18, 2020
Altered third-party punishment in Huntington's disease: A study using neuroeconomic games
Martin Brüne, Sarah Maria von Hein, Christian Claassen, et al.
BMC Medical Genetics
|
October 6, 2005
Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)
Larissa Arning, Peter H Kraus, Carsten Saft, et al.
Neuropsychologia
|
January 29, 2008
fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease
Carsten Saft, Anne Schüttke, Christian Beste, et al.
Neurology
|
May 27, 2021
Teaching Video NeuroImage: New <i>STUB1</i> Variant Causes Chorea, Tremor, Dystonia, Myoclonus, Ataxia, Depression, Cognitive Impairment, Epilepsy, and Superficial Siderosis
Carsten Saft, Sabine Skodda, Huu Phuc Nguyen, et al.
Plos One
|
December 7, 2007
Time processing in Huntington's disease: a group-control study
Christian Beste, Carsten Saft, Jürgen Andrich, et al.
Neurogenetics
|
June 1, 2010
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1
Elahe Taherzadeh-Fard, Carsten Saft, Stefan Wieczorek, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 15, 2013
Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R
Eugen Kloster, Carsten Saft, Denis A Akkad, et al.
BMC Neurology
|
March 2, 2006
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
Carsten Saft, Thorsten Lauter, Peter H Kraus, et al.
Page
of 15